sr 48692 has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ehata, S; Miyauchi, K; Miyazawa, K; Miyazono, K; Morishita, Y; Takahashi, K | 1 |
| Cui, H; Dai, Y; Feng, H; Gong, X; Ouyang, Q; Xiao, H; Xu, L; Xu, M; Yi, L; Zhou, J | 1 |
2 other study(ies) available for sr 48692 and Disease Exacerbation
| Article | Year |
|---|---|
Neurotensin receptor 1 signaling promotes pancreatic cancer progression.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice, Inbred BALB C; Neoplasm Metastasis; NF-kappa B; Pancreatic Neoplasms; Pyrazoles; Quinolines; Receptors, Neurotensin; Signal Transduction | 2021 |
Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Glioma; Humans; Mice; Neoplasm Invasiveness; Neurotensin; Phosphorylation; Prognosis; Protein Precursors; Pyrazoles; Quinolines; Receptors, Neurotensin | 2015 |